Bonum Therapeutics

📍 Seattle, United States🗓 Founded 2021👥 28 employees💰 Last funded 2022
Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Bonum Therapeutics?
Bonum Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Bonum Therapeutics last raise funding?
The most recent investment in Bonum Therapeutics recorded on gritt.io was in 2022.
When was Bonum Therapeutics founded?
Bonum Therapeutics was founded in 2021.
What industry is Bonum Therapeutics in?
Bonum Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bonum Therapeutics based?
Bonum Therapeutics is headquartered in Seattle, United States.